RPRX returns by year
Royalty Pharma plc has returned +5.4% annually (CAGR) since 2021. Calendar-year, monthly and weekly total returns for Royalty Pharma plc (RPRX) below, through August 14, 2026 — the most recent year is year-to-date.
Royalty Pharma plc returns by year (2021–2026)#
Calendar-year returns with each year's path and its dividend contribution (dividend return = total minus price return).
| Year | Start price | End price | Path | Dividend | Total return |
|---|---|---|---|---|---|
| 2026YTD | $38.64 | $58.59 | +1.5% | +53.1% | |
| 2025 | $25.51 | $38.64 | +4.0% | +55.5% | |
| 2024 | $28.09 | $25.51 | +2.7% | -6.5% | |
| 2023 | $39.52 | $28.09 | +1.8% | -27.1% | |
| 2022 | $39.85 | $39.52 | +1.8% | +1.0% | |
| 2021 | $50.05 | $39.85 | +1.3% | -19.1% |
Total return by period
Methodology#
Returns are total returns (dividends reinvested), computed from RPRX's split- and dividend-adjusted closes. The bar chart switches between annual and monthly periods. Annualized return is the compound annual growth rate over the full period. The current year is year-to-date. See also the periodic table of returns. Past performance does not predict future returns; not investment advice.
See also: S&P 500 · Nasdaq-100 · Dow Jones · Russell 2000 · US Bond Market · Gold · Silver · Bitcoin · Ethereum
FAQ#
- What is Royalty Pharma plc's average annual return?
- Since 2021, Royalty Pharma plc (RPRX) has returned about 5.4% a year (the compound annual growth rate) and an average calendar-year return of 0.8%.
- What were Royalty Pharma plc's best and worst years?
- Over 2021–2026, the best year was 2025 (+55.5%) and the worst was 2023 (-27.1%).
- How often is Royalty Pharma plc up in a year?
- 2 of the 5 full years since 2021 were positive — about 40% of the time.